Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical trial phase III, multicenter, randomised, double-blind, double-dummy, parallel treatment design, active-controlled and placebo, to evaluate the analgesic efficacy and safety of ibuprofen arginine/tramadol 400/37.5 mg compared to ibuprofen arginine 400 mg single, tramadol 50 mg single and placebo in patients with moderate to severe pain after dental surgery.

Next Previous
X
Search
Trial Profile

Clinical trial phase III, multicenter, randomised, double-blind, double-dummy, parallel treatment design, active-controlled and placebo, to evaluate the analgesic efficacy and safety of ibuprofen arginine/tramadol 400/37.5 mg compared to ibuprofen arginine 400 mg single, tramadol 50 mg single and placebo in patients with moderate to severe pain after dental surgery.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Apr 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ibuprofen arginine/tramadol (Primary) ; Ibuprofen; Tramadol
  • Indications Dental pain
  • Focus Therapeutic Use
  • Sponsors Farmalider

    • Most Recent Events

    • 01 Apr 2021 Results (N=118) assessment of influence of genetic polymorphisms (pharmacogenetic assessment) published in the Clinical Therapeutics
    • 23 May 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
    • 10 Feb 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top